Adrenal insufficiency in growth hormone-treated patients: A reassessment

Pediatric Endocrinology Reviews

Volumn 3, Issue SUPPL. 2, 2006, Pages 328-332

  Rapaport, Robert ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Addison's disease; Adrenal insufficiency; Mortality risks, growth hormone recipients, growth hormone deficiency

Indexed keywords

CORTICOTROPIN; GONADORELIN; GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; PROLACTIN; TESTOSTERONE; THYROTROPIN; THYROXINE;

ADDISON DISEASE; ADRENAL CORTEX INSUFFICIENCY; ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; ANAMNESIS; CASE REPORT; CREUTZFELDT JAKOB DISEASE; ENDOCRINE FUNCTION TEST; GONADOTROPIN RELEASING HORMONE DEFICIENCY; GROWTH HORMONE DEFICIENCY; HIGH RISK PATIENT; HORMONAL THERAPY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; MORBIDITY; MORTALITY; PROVOCATION TEST; REVIEW; RISK ASSESSMENT; SCHOOL CHILD; SUBSTITUTION THERAPY; SYMPTOMATOLOGY;

EID: 33646234450     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Buchanan CR, Preece MA, Milner RD. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ 1991;302:824-828
2. Mills JL, Schonberger LB, Wysowski DK, Brown P, Durako SJ, Cox C, Kong F, Fradkin JE. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr 2004;144:430-436
3. Taback SP, Dean HJ. Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee. J Clin Endocrinol Metab 1996;81:1693-1696
4. Lange M, Feldt-Rasmussen U, Svendsen OL, Kastrup KW, Juul A, Muller J. High risk of adrenal insufficiency in adults previously treated for idiopathic childhood onset growth hormone deficiency. J Clin Endocrinol Metab 2003;88:5784-5789
5. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 2000;85:3990-3993
6. Hartman ML. The Growth Hormone Research Society consensus guidelines for the diagnosis and treatment of adult GH deficiency. Growth Horm IGF Res 1998;8(suppl A):25-29
7. Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M. European Society of Paediatric Endocrinology. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 2005;152:165-170
8. Maghnie M, Uga E, Temporini F, Di Iorgi N, Secco A, Tinelli C, Papalia A, Casini MR, Loche S. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemic, low-dose ACTH, standard ACTH and CRH stimulation tests. Eur J Endocrinol 2005;152:735-741
9. Hintz RL. Eternal vigilance-mortality in children with growth hormone deficiency. J Clin Endocrinol Metab 1996;81:1691-1692
10. Cutler GB Jr, Chipman JJ. Treatment of hypopituitary children. J Pediatr 2004;144:415-416
11. Hoffman AR, Biller BM, Cook D, Baptista J, Silverman BL, Dao L, Attie KM, Fielder P, Maneatis T, Lippe B. Genentech Adult Growth Hormone Deficiency Study Group. Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. J Clin Endocrinol Metab 2005;90:6431-6440
12. Ten S, New M, Maclaren N. Clinical Review 130: Addison's disease 2001. J Clin Endocrinol Metab 2001;86:2909-2922